İşlek Akif, Balcı Mustafa Koray
Nusaybin State Hospital, Otolaryngology-Head & Neck Surgery Clinic, Mardin, Turkey.
Otolaryngology-Head & Neck Surgery Clinic, Katip Celebi University, Atatürk Training and Research Hospital, Izmir, Turkey.
Ear Nose Throat J. 2022 May;101(4):234-238. doi: 10.1177/0145561321996621. Epub 2021 Feb 19.
To analyze factors regarding patient characteristics, sampling techniques, and coronavirus disease 2019 (COVID-19) specific manifestations that may cause false-negative reverse-transcription polymerase chain reaction (RT-PCR).
A cross-sectional study was conducted. For the diagnosis of COVID-19, patients with RT-PCR test positive in the first nasopharyngeal and oropharyngeal swabs were accepted as true positive, and patients with negative 3 consecutive swab results were considered true negative. Those who had a negative initial swab were considered false negatives if they subsequently tested positive on the second or third swab. Demographic data of the patients, the onset of the disease, presence of nasal septal deviation, presence of epistaxis, the clinician (otolaryngologist/other physicians [OP]) who collected the samples, and medical treatments for laryngopharyngeal reflux, allergic respiratory diseases, allergic rhinitis, which include proton pump inhibitors and nasal steroids (NS), were documented. The analysis of dependent variables was performed with the chi-square test. Binary logistic regression was performed for significant variables.
A total of 399 patients were included in the study, and 357 (89.5%) patients were detected as positive after 2 or 3 consecutive RT-PCR tests. The presence of ageusia, anosmia, and collecting the samples within 7 days following the onset of symptoms were determined as significant factors for positive RT-PCR results ( = <.001; odds ratio [OR] = 6.2, 5.8, 11.6, respectively). The profession of the clinician (OP), NS use, and the presence of epistaxis were detected as significant factors for the false-negative RT-PCR results ( < .001; OR = 2.3, 3.1, 8.7, respectively).
Patient- and/or sample-related factors can affect RT-PCR results of possible COVID-19 cases. The presence of these factors can easily be determined in cases with high clinical suspicion and negative RT-PCR results. The presence of ageusia, anosmia, early sampling (<7days), and appropriate collection of swabs decrease false-negative RT-PCR results.
分析患者特征、采样技术以及2019冠状病毒病(COVID-19)的特定表现等可能导致逆转录聚合酶链反应(RT-PCR)假阴性的因素。
开展一项横断面研究。对于COVID-19的诊断,首次鼻咽拭子和口咽拭子RT-PCR检测呈阳性的患者被视为真阳性,连续3次拭子检测结果均为阴性的患者被视为真阴性。初始拭子检测为阴性但随后第二次或第三次拭子检测呈阳性的患者被视为假阴性。记录患者的人口统计学数据、疾病发作情况、鼻中隔偏曲情况、鼻出血情况、采集样本的临床医生(耳鼻喉科医生/其他医生[OP]),以及针对咽喉反流、过敏性呼吸道疾病、过敏性鼻炎的药物治疗情况,这些治疗包括质子泵抑制剂和鼻用类固醇(NS)。采用卡方检验对因变量进行分析。对显著变量进行二元逻辑回归分析。
本研究共纳入399例患者,357例(89.5%)患者在连续2次或3次RT-PCR检测后被检测为阳性。味觉减退、嗅觉丧失以及在症状出现后7天内采集样本被确定为RT-PCR结果呈阳性的显著因素(P = <.001;比值比[OR]分别为6.2、5.8、11.6)。临床医生(OP)的职业、使用NS以及鼻出血被检测为RT-PCR结果假阴性的显著因素(P <.001;OR分别为2.3、3.1、8.7)。
患者和/或样本相关因素会影响疑似COVID-19病例的RT-PCR结果。在临床高度怀疑但RT-PCR结果为阴性的病例中,这些因素很容易被确定。味觉减退、嗅觉丧失、早期采样(<7天)以及正确采集拭子可减少RT-PCR结果的假阴性。